Due to health issues, this site is no longer maintained and will be shut down shortly. |
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. It develops and commercializes Parsortix cell separation system, which captures and harvests rare circulating tumor cells in cancer patient blood; and Ziplex multiplex analysis system that is used with the ovarian cancer clinical application and others. The company was founded in 2004 and is based in Guildford, the United Kingdom.This company has ADRs that trade in the U.S. as the symbol ANPCY.
19.50 GBP
As of 03/22/2023
2022 © Stock Market MBA, Inc.